Responding to Ventricular Assist Device Recalls: An Ethical Guide for Mechanical Circulatory Support Programs.

Area of Science:

• Medical Ethics
• Cardiovascular Surgery
• Biomedical Engineering

Background:

• Cardiac device recalls, such as the 2018 Abbott HeartMate 3 and Medtronic HVAD events, present significant ethical challenges for Mechanical Circulatory Support (MCS) programs.
• These recalls impact patients with existing Ventricular Assist Devices (VADs), their caregivers, and individuals undergoing consideration for new VAD implantation.

Purpose of the Study:

• To examine the ethical obligations of MCS programs during cardiac device recalls.
• To analyze the implications of recalls on informed consent and shared decision-making processes for VAD patients.

Main Methods:

• Ethical analysis of responsibilities in the context of simultaneous VAD recalls.
• Review of communication protocols and disclosure gaps between manufacturers, MCS programs, and patients.

Main Results:

• MCS programs face a disclosure gap, often learning about recalls after public announcements, complicating timely patient notification.
• Ethical imperatives demand that MCS teams proactively communicate recall information, including risks and management strategies, to all affected patients.

Conclusions:

• MCS programs have a critical ethical duty to ensure transparent and timely communication with patients regarding cardiac device recalls.
• Addressing the disclosure gap and upholding informed consent are paramount for maintaining patient trust and ethical practice in VAD therapy.